Cargando…

Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors

Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hubertus, Jochen, Zitzmann, Ferdinand, Trippel, Franziska, Müller-Höcker, Josef, Stehr, Maximilian, von Schweinitz, Dietrich, Kappler, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692448/
https://www.ncbi.nlm.nih.gov/pubmed/23825673
http://dx.doi.org/10.1371/journal.pone.0067605
_version_ 1782274615986356224
author Hubertus, Jochen
Zitzmann, Ferdinand
Trippel, Franziska
Müller-Höcker, Josef
Stehr, Maximilian
von Schweinitz, Dietrich
Kappler, Roland
author_facet Hubertus, Jochen
Zitzmann, Ferdinand
Trippel, Franziska
Müller-Höcker, Josef
Stehr, Maximilian
von Schweinitz, Dietrich
Kappler, Roland
author_sort Hubertus, Jochen
collection PubMed
description Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT.
format Online
Article
Text
id pubmed-3692448
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36924482013-07-02 Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors Hubertus, Jochen Zitzmann, Ferdinand Trippel, Franziska Müller-Höcker, Josef Stehr, Maximilian von Schweinitz, Dietrich Kappler, Roland PLoS One Research Article Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT. Public Library of Science 2013-06-25 /pmc/articles/PMC3692448/ /pubmed/23825673 http://dx.doi.org/10.1371/journal.pone.0067605 Text en © 2013 Hubertus et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hubertus, Jochen
Zitzmann, Ferdinand
Trippel, Franziska
Müller-Höcker, Josef
Stehr, Maximilian
von Schweinitz, Dietrich
Kappler, Roland
Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title_full Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title_fullStr Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title_full_unstemmed Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title_short Selective Methylation of CpGs at Regulatory Binding Sites Controls NNAT Expression in Wilms Tumors
title_sort selective methylation of cpgs at regulatory binding sites controls nnat expression in wilms tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692448/
https://www.ncbi.nlm.nih.gov/pubmed/23825673
http://dx.doi.org/10.1371/journal.pone.0067605
work_keys_str_mv AT hubertusjochen selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT zitzmannferdinand selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT trippelfranziska selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT mullerhockerjosef selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT stehrmaximilian selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT vonschweinitzdietrich selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors
AT kapplerroland selectivemethylationofcpgsatregulatorybindingsitescontrolsnnatexpressioninwilmstumors